Patents Assigned to NANJING NORATECH PHARMACEUTICALS CO., LTD.
  • Aripiprazole injectable suspension formulation having prolonged shelf life
    Patent number: 11786522
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: October 17, 2023
    Assignee: Nanjing Noratech Pharmaceuticals Co., LTD
    Inventors: Yunzhe Sun, Qi Peng, Cheng-Gang Lin, Li Gui, Zhihui Liu, Fei Liu
  • ARIPIPRAZOLE INJECTABLE SUSPENSION FORMULATION HAVING PROLONGED SHELF LIFE
    Publication number: 20230255960
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Applicant: NANJING NORATECH PHARMACEUTICALS CO., LTD.
    Inventors: Yunzhe SUN, Qi PENG, Cheng-Gang LIN, Li GUI, Zhihui LIU, Fei LIU
  • Crystalline form of aripiprazole
    Patent number: 10913721
    Abstract: The present invention relates to a crystalline form N of aripiprazole, pharmaceutical compositions thereof and the use of crystalline form N in the preparation of a medicament for the treatment of central nervous system diseases, especially schizophrenia.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: February 9, 2021
    Assignee: NANJING NORATECH PHARMACEUTICALS CO., LTD
    Inventors: Yun-Zhe Sun, Wei-Ming Jiang, Xin Zhao, Cheng-Gang Lin, Li Gui, Fei Liu
  • Crystal forms of valsartan disodium salt
    Patent number: 10745363
    Abstract: Provided are crystal forms A, B, D, E, F, G and H of valsartan disodium salt and a preparation method therefor.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: August 18, 2020
    Assignee: NANJING NORATECH PHARMACEUTICALS CO., LTD
    Inventors: Fei Liu, Gang Wu, Weiming Jiang, Cheng-Gang Lin, Xuan Cai, Ping Lin, Yuling Lu, Lixiang Liu
  • POMALIDOMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR
    Publication number: 20200199097
    Abstract: Disclosed in the present invention are a Pomalidomide derivative and a preparation method therefor. Specifically, the present invention relates to the Pomalidomide derivative and a stereoisomer thereof, or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating cancers.
    Type: Application
    Filed: August 21, 2017
    Publication date: June 25, 2020
    Applicant: NANJING NORATECH PHARMACEUTICALS CO., LTD
    Inventors: Fei LIU, Gang WU, Xin ZHAO, Pan CHEN, Yunpeng LIAO, Xiaobo WANG, Zhi QI, Xudong YANG
  • Crystalline form of sacubitril sodium salt
    Patent number: 10683260
    Abstract: Provided are new crystalline forms A, B, C, D and E of sacubitril sodium salt and a method for preparation thereof, pharmaceutical compositions thereof, and application thereof in preparing drugs for enkephalinase-related diseases.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: June 16, 2020
    Assignee: NANJING NORATECH PHARMACEUTICALS CO., LTD.
    Inventors: Fei Liu, Gang Wu, Weiming Jiang, Cheng-Gang Lin, Xuan Cai, Ping Lin, Yuling Lu, Lixiang Liu
  • Donepezil derivative and use thereof
    Patent number: 10632111
    Abstract: The present invention relates to a donepezil derivative of general formula (I) or a pharmaceutically acceptable salt thereof, wherein R in the formula is as disclosed herein; and a method for preparation thereof; and a composition comprising an effective amount of a compound of the general formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to use of a compound of the general formula (I) or a pharmaceutically acceptable salt thereof in preparing a medicament for treating a disease resulted from an abnormality in acetylcholinesterase activity.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 28, 2020
    Assignee: NANJING NORATECH PHARMACEUTICALS CO., LTD.
    Inventors: Fei Liu, Cuixia Zhang, Chenggang Lin, Chunyan Zhou, Pan Chen, Wei Wang, Lulu Wang